In this work, we studied the immunohistochemical expression of the kinases PI3K, PINK1, and PD-L1 in a specific subset of patients with lung adenocarcinomas—only those who underwent surgical resection of their BM—to better describe molecular alterations at this stage of advanced disease. Here, PINK1 is linked to lung adenocarcinoma.